Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Everyone taking part will receive empagliflozin. In addition, half the people taking part in this study will get the active BI 690517 pill and half will get the dummy inactive pill (known as placebo). Which treatment you get will be decided by the computer by chance (like tossing a coin). This is called randomisation.

Neither you nor your doctors will know which treatment you are given and the study staff will not know either. This ensures the study gives results that are reliable and trustworthy.

Image of two orange boxes with white icons of people. The top box is labelled 'Before the trial'. The second box is labelled 'Throughout the trial' and shows the icons of people in two separate groups. Under one group there are the labels 'Empaglaflozin' and 'BI690517'. Under the second group, there are the labels 'Empaglaflozin' and 'Placebo'. There is an icon of dice in between the two orange boxes.